Here are three things to know:
1. Mr. Marino told President Donald Trump he was withdrawing, which President Trump later tweeted Oct. 17.
2. The withdrawal comes after The Washington Post and CBS published an investigation Oct. 15 into Mr. Marino’s role in pushing a law that supported the drug industry. Specifically, the 2016 law eased prescription narcotic delivery.
3. Following the publication, critics voiced concern over Mr. Marino’s commitment to curbing opioid abuse. Senate Minority Leader Chuck Schumer, D-N.Y., and Sen. Joe Manchin, D-W.V., both turned to President Trump to revoke the nomination.
More articles on practice management:
The Villages Health opens 8th care center, adds orthopedic specialist: 5 insights
Advance Spine & Pain Center combats security breach: 5 key points
AMA jumpstarts its Integrated Health Model Initiative : 6 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
